TrHLINE - Joint injections (linear HA 1%/2%)

TrHLINE - Joint injections (linear HA 1%/2%)
Product Description

TrHLINE is a linear hyaluronic acid injection, designed for intra-articular administration to restore the viscoelastic properties of synovial fluid in traumatic and degenerative lesions of the joints, manifested by pain syndrome and reduced mobility.

TrHLINE is available in 2 models with different concentrations (1% and 2%) to select the most appropriate treatment for each patient.

Composition
TrHLINE contains high molecular weight hyaluronic acid obtained by biofermentation of injectable grade and high purity, dissolved in a physiological buffer with pharmacopeia quality ingredients and water for injections.

Properties
+ Lubricating effect.
+ Shock absorption.
+ Reduction of pain in the joint.
+ Improves mobility and quality of life.
+ Increases the functionality of the joint.
+ Easily reabsorbed by the body.

Read more Show less

i+Med S. Coop.

  • ES
  • 2018
    On CPHI since
  • 3
    Certificates
  • 50 - 99
    Employees
Company types
Contract Service
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    9004-61-9
  • Supplied from
    Spain
More specifications Fewer specifications
Sales Markets
Show more Show less

i+Med S. Coop.

  • ES
  • 2018
    On CPHI since
  • 3
    Certificates
  • 50 - 99
    Employees
Company types
Contract Service
View company profile

More Products from i+Med S. Coop. (4)

  • ADAPTEK® TECHNOLOGY

    Product ADAPTEK® TECHNOLOGY

    ADAPTEK® TECHNOLOGY is the general name for our 4 international patents and expertise in nanotechnology and controlled release systems.This is a transversal technology that allows to develop customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.)....
  • OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    Product OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    OpHLINE is an ophthalmic viscosurgical devise (OVD) indicated as a coadjuvant during surgical procedures, involving the anterior chamber of the eye, especially in cataract surgery, including the extraction of the lens and the insertion of intraocular lenses.
    OpHLINE is available in 3 models ...
  • TrHCROSS - Joint injections (cross-linked HA 2%)

    Product TrHCROSS - Joint injections (cross-linked HA 2%)

    TrHCROSS 2% is a biocompatible hydrogel of cross-linked sodium hyaluronate obtained by biofermentation. This is a single injection, designed to relieve joint pain in osteoarthritis by replacing natural joint fluid and replenishing lubricating and shock-absorbing functions.

    Properties
    ...
  • BtHLINE - Dermal filler for biorevitalization (linear HA 1,4%)

    Product BtHLINE - Dermal filler for biorevitalization (linear HA 1,4%)

    BtHLINE is a biocompatible linear hyaluronic acid hydrogel intended as a dermatologicaltreatment for aesthetic purposes. Administered by intradermal injection, the product is indicated to complement the extracellular matrix and intradermal tissue, restoring the anatomical structures of the skin, promot...

i+Med S. Coop. resources (2)

  • i+Med Company profile

    Brochure i+Med Company profile

    i+Med is a biotech company formed by highly qualified personnel, focused on the R&D and manufacture of new products for third parties. Our ADAPTEK® TECHNOLOGY enables the development of customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.). These intelligent nanoparticles could be programmed to respond to external stimulus (E.g. pH or t˚) that allow the controlled release of APIs. As a result, we can develop high added value and differentiated products that provide our customers with a key competitive advantage in t...

  • Company video presentation

    Video Company video presentation

    i+Med is a company involved in the research, development and manufacture of new products in the field of biomedical engineering. 

     We specialize in the generation of intelligent Nanohydrogels and customized smart systems for controlled release adapted to the needs of each client, always under a strict control of the manufacturing process and a demanding quality policy.  
    More information at https://imasmed.com/en/